Silverback Asset Management »

Travere Therapeutics shares owned by Silverback Asset Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Silverback Asset Management from 13F filings

Historical chart of Silverback Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Silverback Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Silverback Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $11B 13M 864.35
2024-06-30 $9.8B 15M 650.52
2024-03-31 $11M 17M 0.64
2023-09-30 $8.1B 13M 647.46